Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK)

May 24, 2018 7:05 AM

Foundation Medicine, Inc. (NASDAQ: FMI) today announced a collaboration with Merck (NYSE: MRK), known as MSD outside the United States ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found